AR014539A1 - Derivados de 5'-desoxicitidina, una composicion farmaceutica y kit que los comprende, el uso de los mismos para la fabricacion de un medicamento - Google Patents
Derivados de 5'-desoxicitidina, una composicion farmaceutica y kit que los comprende, el uso de los mismos para la fabricacion de un medicamentoInfo
- Publication number
- AR014539A1 AR014539A1 ARP990100469A ARP990100469A AR014539A1 AR 014539 A1 AR014539 A1 AR 014539A1 AR P990100469 A ARP990100469 A AR P990100469A AR P990100469 A ARP990100469 A AR P990100469A AR 014539 A1 AR014539 A1 AR 014539A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- kit
- manufacture
- pharmaceutical composition
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/167—Purine radicals with ribosyl as the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Derivados de 5-desoxicitidina que comprende un compuesto representado por la formula general (I) en el que R1 es cada uno independientemente hidrogeno oun grupo fácilmente hidrolizable en condiciones fisiologicas; R2 es -(CH2)n- cicloalquilo [en donde cicloalquilo contiene de 3 a 5 átomos de carbono, n esun entero de 0 a 4], heteroaril-(alquilo-inferior), (alcoxi-inferior)-(alquilo- inferior), ariloxi-(alquilo-inferior), aralquiloxi-(alquilo-inferior),(alquiltio-inferior)-(alquilo-inferior), ariltio-(alquilo-inferior), aralquiltio-(alquilo-inferior), oxo-(alquilo-inferior), acilamino-(alquilo-inferior), amino cíclico-(alquilo-inferior), (amino 2-oxocíclico)-(alquilo- inferior), en donde la cadena alquileno puede estar sustituida adicionalmentecon uno o dos grupos alquilo-inferior y R3 es yodo, un grupo vinilo o etinilo, (dichos grupos pueden estar sustituidos con un átomo o átomos de halogeno,alquilo C1-4,cicloalquilo, aralquilo, o un anillo aromático que puede presentar uno o más heteroátomos], una composicion farmacéutica y kit que los comprende,el uso de los mismos para la fabricacion de un medicamento antitumoral.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98102080 | 1998-02-06 | ||
EP98108321 | 1998-05-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR014539A1 true AR014539A1 (es) | 2001-02-28 |
Family
ID=26149007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP990100469A AR014539A1 (es) | 1998-02-06 | 1999-02-04 | Derivados de 5'-desoxicitidina, una composicion farmaceutica y kit que los comprende, el uso de los mismos para la fabricacion de un medicamento |
Country Status (19)
Country | Link |
---|---|
US (1) | US6005098A (es) |
EP (1) | EP1060183B1 (es) |
JP (2) | JP3625276B2 (es) |
KR (1) | KR100381516B1 (es) |
CN (1) | CN1260240C (es) |
AR (1) | AR014539A1 (es) |
AT (1) | ATE238335T1 (es) |
AU (1) | AU757136B2 (es) |
BR (1) | BR9907672A (es) |
CA (1) | CA2318848C (es) |
CO (1) | CO5070642A1 (es) |
DE (1) | DE69907161T2 (es) |
DK (1) | DK1060183T3 (es) |
ES (1) | ES2195543T3 (es) |
MA (1) | MA26606A1 (es) |
PE (1) | PE20000244A1 (es) |
PT (1) | PT1060183E (es) |
TR (1) | TR200002297T2 (es) |
WO (1) | WO1999040099A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030119724A1 (en) * | 1995-11-22 | 2003-06-26 | Ts`O Paul O.P. | Ligands to enhance cellular uptake of biomolecules |
EP0882734B1 (en) * | 1997-06-02 | 2009-08-26 | F. Hoffmann-La Roche Ag | 5'-Deoxy-cytidine derivatives |
EP1057831B1 (en) | 1999-05-26 | 2004-09-22 | F. Hoffmann-La Roche Ag | Process for the preparation of vinyl pyrimidine derivatives |
KR100631754B1 (ko) * | 2000-08-09 | 2006-10-09 | 주식회사 코오롱 | N-알킬옥시카르보닐-5-플루오로사이토신 유도체 및 그의제조방법 |
AU2002217980A1 (en) | 2000-12-01 | 2002-06-11 | Cell Works Inc. | Conjugates of glycosylated/galactosylated peptide |
CN100383128C (zh) * | 2004-02-23 | 2008-04-23 | 上海迪赛诺医药发展有限公司 | N4-氧羰基胞嘧啶衍生物及制备方法与应用 |
JP2008535920A (ja) * | 2005-04-12 | 2008-09-04 | エラン・ファルマ・インターナショナル・リミテッド | 癌の治療のための、フルオロシチジン誘導体を含む改変放出組成物 |
JP6866113B2 (ja) * | 2016-11-01 | 2021-04-28 | 日本化薬株式会社 | カペシタビンを有効成分とする医薬製剤 |
JP6792418B2 (ja) * | 2016-11-08 | 2020-11-25 | 日本化薬株式会社 | カペシタビンを有効成分とする医薬製剤の製造方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1561290A (en) * | 1975-10-16 | 1980-02-20 | Nyegaard & Co As | Pyrimid - 2 - ones |
JPS54129131A (en) * | 1978-03-27 | 1979-10-06 | Taiho Pharmaceutical Co Ltd | Antiimalignant tumor agent composition |
GB2016921B (en) * | 1978-03-27 | 1982-08-18 | Taiho Pharmaceutical Co Ltd | Anti cancer compositions containing uracil derivatives |
US4328229A (en) * | 1978-03-29 | 1982-05-04 | Taiho Pharmaceutical Company Limited | Anti-cancer composition for delivering 5-fluorouracil to cancer tissues |
CA1327358C (en) * | 1987-11-17 | 1994-03-01 | Morio Fujiu | Fluoro cytidine derivatives |
EP0711555A2 (en) * | 1990-07-19 | 1996-05-15 | The Wellcome Foundation Limited | Enzyme inactivators |
GB9020930D0 (en) * | 1990-09-26 | 1990-11-07 | Wellcome Found | Pharmaceutical combinations |
AU654555B2 (en) * | 1991-05-27 | 1994-11-10 | Taiho Pharmaceutical Co., Ltd. | Composition, method and kit for potentiating antitumor activity and for curing tumor |
AU671491B2 (en) * | 1992-12-18 | 1996-08-29 | F. Hoffmann-La Roche Ag | N-oxycarbonyl substituted 5'-deoxy-5-fluorcytidines |
TW254946B (es) * | 1992-12-18 | 1995-08-21 | Hoffmann La Roche | |
EP0882734B1 (en) * | 1997-06-02 | 2009-08-26 | F. Hoffmann-La Roche Ag | 5'-Deoxy-cytidine derivatives |
-
1999
- 1999-01-20 US US09/234,200 patent/US6005098A/en not_active Expired - Fee Related
- 1999-02-02 PE PE1999000082A patent/PE20000244A1/es not_active Application Discontinuation
- 1999-02-03 TR TR2000/02297T patent/TR200002297T2/xx unknown
- 1999-02-03 PT PT99907492T patent/PT1060183E/pt unknown
- 1999-02-03 JP JP2000530527A patent/JP3625276B2/ja not_active Expired - Fee Related
- 1999-02-03 WO PCT/EP1999/000710 patent/WO1999040099A1/en active IP Right Grant
- 1999-02-03 ES ES99907492T patent/ES2195543T3/es not_active Expired - Lifetime
- 1999-02-03 BR BR9907672-1A patent/BR9907672A/pt not_active Application Discontinuation
- 1999-02-03 CN CNB998027588A patent/CN1260240C/zh not_active Expired - Fee Related
- 1999-02-03 KR KR10-2000-7008488A patent/KR100381516B1/ko not_active IP Right Cessation
- 1999-02-03 DK DK99907492T patent/DK1060183T3/da active
- 1999-02-03 CA CA002318848A patent/CA2318848C/en not_active Expired - Fee Related
- 1999-02-03 EP EP99907492A patent/EP1060183B1/en not_active Expired - Lifetime
- 1999-02-03 AU AU27227/99A patent/AU757136B2/en not_active Ceased
- 1999-02-03 AT AT99907492T patent/ATE238335T1/de not_active IP Right Cessation
- 1999-02-03 DE DE69907161T patent/DE69907161T2/de not_active Expired - Fee Related
- 1999-02-04 AR ARP990100469A patent/AR014539A1/es unknown
- 1999-02-04 CO CO99006410A patent/CO5070642A1/es unknown
- 1999-02-05 MA MA25456A patent/MA26606A1/fr unknown
-
2004
- 2004-07-06 JP JP2004199438A patent/JP2004339230A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2004339230A (ja) | 2004-12-02 |
KR100381516B1 (ko) | 2003-04-23 |
AU757136B2 (en) | 2003-02-06 |
KR20010072543A (ko) | 2001-07-31 |
DE69907161T2 (de) | 2004-02-05 |
MA26606A1 (fr) | 2004-12-20 |
DE69907161D1 (de) | 2003-05-28 |
PT1060183E (pt) | 2003-08-29 |
ES2195543T3 (es) | 2003-12-01 |
CO5070642A1 (es) | 2001-08-28 |
EP1060183B1 (en) | 2003-04-23 |
AU2722799A (en) | 1999-08-23 |
JP3625276B2 (ja) | 2005-03-02 |
DK1060183T3 (da) | 2003-08-11 |
BR9907672A (pt) | 2000-11-28 |
WO1999040099A1 (en) | 1999-08-12 |
CA2318848C (en) | 2008-09-02 |
CN1290269A (zh) | 2001-04-04 |
CN1260240C (zh) | 2006-06-21 |
JP2002502857A (ja) | 2002-01-29 |
TR200002297T2 (tr) | 2000-12-21 |
ATE238335T1 (de) | 2003-05-15 |
PE20000244A1 (es) | 2000-04-10 |
CA2318848A1 (en) | 1999-08-12 |
US6005098A (en) | 1999-12-21 |
EP1060183A1 (en) | 2000-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2218922C2 (ru) | Соединения, имеющие в своей структуре фрагмент производного глюкуроновой кислоты и фрагмент производного глюкозамина, способы получения этих соединений и применение этих соединений | |
AR016001A1 (es) | Uso de polimeros de amina alifatica para la fabricacion de medicamentos para la reduccion de niveles de oxalato en un paciente | |
NO20002851L (no) | Blandinger for nasal administrasjon av medikamenter | |
AR025959A1 (es) | DERIVADOS DE TER.-BUTIL-(7-METIL-IMIDAZO[1,2,a]PIRIDIN-3-IL)-AMINA, PROCEDIMIENTO PARA SU PREPARACION, MEDICAMENTOS QUE LOS CONTIENEN, SU USO PARA LAPREPARACION DE UN MEDICAMENTO PARA LA INHIBICION DE NO-SINTASA Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN | |
PT1073470E (pt) | Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos | |
FI964920A (fi) | Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet | |
MXPA02003199A (es) | Derivados de sulfonamida farmaceuticamente activos. | |
KR900012911A (ko) | 흥분성 아미노산 수용기 길항질 화합물 | |
ES2173074T3 (es) | Derivados de xantina, procedimiento para su preparacion y su uso farmaceutico. | |
PL350967A1 (en) | Pharmaceutical compounds | |
AR018634A1 (es) | Derivados de benzo(b)tiepin-1,1,-dioxido, procedimiento para su preparacion, medicamentos conteniendo estos compuestos, procedimiento para la preparacion de medicamentos y su empleo para la preparacion de medicamentos. | |
FR2654104B1 (fr) | Nouveaux derives du 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. | |
KR910015575A (ko) | 1H-이미다조[4,5-c]퀴놀린-4-아민 | |
ES2061848T3 (es) | Compuestos triciclos, procedimientos para su preparacion y composiciones farmaceuticas que los comprenden. | |
AR014539A1 (es) | Derivados de 5'-desoxicitidina, una composicion farmaceutica y kit que los comprende, el uso de los mismos para la fabricacion de un medicamento | |
KR890014098A (ko) | 카테콜 아민 유도체를 함유하여 이루어지는 중추성 신경퇴행성 질환의 진행방지 및 치료제 | |
ES2064461T3 (es) | Derivados de xantina, procedimiento para su preparacion y composicion farmaceutica. | |
EP1193256A8 (en) | Pharmaceutically active benzsulfonamide derivatives as inhibitors of JNK proteins | |
ES2087252T3 (es) | Uso de derivados de dioxabiciclo(3.3.0)octano para la preparacion de un medicamento para inhibir el metabolismo del colesterol. | |
HUP0301030A2 (hu) | Kardiális aritmiák kezelésére alkalmazható új aza-biciklooktán-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
KR900003105A (ko) | N-2,3-부타디엔일 트리- 및 테트라아미노알칸 유도체 | |
ES2059625T3 (es) | Un procedimiento para preparar un derivado de hidroxialquilcisteina. | |
AR004691A1 (es) | Nuevos derivados de [3-alcoxi-fenoxi-)-etil]-dialquilamina, una composicion farmaceutica que los comprende, su uso como anestesicos locales y unprocedimiento para su preparacion | |
AR008543A1 (es) | Un compuesto de camptotecina, un medicamento, una composicion farmaceutica que lo comprende y el uso del compuesto. | |
KR910007523A (ko) | 과콜레스테린혈증, 과지방혈증 및 혈전색전증 질병 치료용 토코트리엔올 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |